Page results
-
A lung cancer patient at UCLH is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells.
-
This page tells you about having a Port-a-cath Insertion (implantable port) with the Interventional Radiology team.
-
With all eyes on Paris for this summer’s Olympic Games, we look at how UCLH’s Institute of Sport, Health and Exercise (ISEH) has supported one of Britian’s Olympic hopefuls, and the care it provides for all kinds of sportspeople, from professionals to weekend warriors.
-
UCLH is one of the largest blood cancers treatment centres in Europe, with both inpatient beds and a comprehensive day care service. The service is the main treatment centre for patients from north and east London, and west Essex.
-
Find more information on bites, stings and animal related injuries.
-
A new BBC documentary, The Jennings vs Alzheimer’s, explores the discoveries made by researchers at UCL and UCLH that have given hope for Alzheimer’s disease over the past four decades, and the very special family that helped make it happen. The Jennings vs Alzheimer’s airs on BBC Two at 9pm on Monday 13th May 2024 and will be available on BBC iPlayer afterwards.
-
The palliative care team at UCLH provides specialist palliative and end-of-life care to any patient who has a life-limiting illness, and offers support to families and carers.
-
Taking care of yourself before and during cancer treatment can make a big difference. It can help reduce treatment side effects and make you feel stronger, both physically and emotionally. It can also help you feel more in control of what's happening.
-
UCLH is the London Cancer Centre for the surgical treatment of prostate cancer.
-
Information about activating your MyCare UCLH app.
File results
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust